SELLAS Life Sciences Group, Inc. — Director's Dealing 2014

Sep 19, 2014

SEC Form 4/A — Form 4/A

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-06-30

Reporting Person: Ahn Mark J (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-30	Common Stock	A	2461	$2.6	Acquired	116225	Direct

Footnotes

F1: The shares shown were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. The Reporting Person's original Form 4 reported the acquisition of the shares using transaction code "J" instead of transaction code "A", which code is reflected in this amended Form 4.